Sumitomo Chemical India (SUMICHEM) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
5 Sep, 2025Executive summary
Achieved record Q1FY26 revenue of ₹1,056.8 crore, up 26% year-over-year, with robust domestic demand and improved product mix driving growth.
EBITDA rose 36% to ₹219.2 crore, and net profit increased 41% to ₹178.1 crore, reflecting operating leverage and margin expansion.
Standalone and consolidated unaudited financial results for the quarter ended 30 June 2025 were reviewed and approved by the Board on 4 August 2025.
The business is seasonal, with performance influenced by monsoon and climatic conditions.
Early and surplus monsoon supported strong kharif sowing and channel inventory build-up, boosting agrochemical demand.
Financial highlights
Standalone revenue from operations for Q1 FY26 was ₹10,480.69 million, up from ₹8,317.84 million in Q1 FY25 and ₹6,648.02 million in Q4 FY25.
Consolidated revenue from operations for Q1 FY26 was ₹10,567.79 million, up from ₹8,388.87 million in Q1 FY25 and ₹6,794.21 million in Q4 FY25.
EBITDA margin improved to 20.7% from 19.2% year-over-year.
Net profit margin rose to 16.9% from 15.1% in Q1FY25.
Basic and diluted EPS (consolidated) for Q1 FY26 was ₹3.57, up from ₹2.54 in Q1 FY25 and ₹2.00 in Q4 FY25.
Outlook and guidance
IMD projects normal to above-normal monsoon for the remainder of the season, supporting positive outlook for kharif crop and agrochemical demand.
Company’s performance is expected to remain seasonal, with results dependent on monsoon and climatic factors.
Continued focus on differentiated offerings, digital engagement, and operational agility to sustain growth.
Latest events from Sumitomo Chemical India
- 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/2630 Jan 2026 - Record H1 FY25 profit and margin growth driven by new products, exports, and strong demand outlook.SUMICHEM
Q2 24/2518 Jan 2026 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/257 Jan 2026 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/2628 Oct 2025 - Q1FY25 saw strong revenue and profit growth, improved margins, and ongoing legal and seasonal risks.SUMICHEM
Q1 24/255 Sep 2025 - Q3FY25 saw robust revenue and profit growth, led by exports, with ongoing seasonal and regulatory risks.SUMICHEM
Q3 24/255 Sep 2025